{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:28:40Z","timestamp":1771295320998,"version":"3.50.1"},"reference-count":54,"publisher":"Korean College of Neuropsychopharmacology","issue":"1","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2314-B-182A-059-"],"award-info":[{"award-number":["MOST 105-2314-B-182A-059-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2021,2,28]]},"DOI":"10.9758\/cpn.2021.19.1.135","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:04:03Z","timestamp":1611824643000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease"],"prefix":"10.9758","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-8968","authenticated-orcid":false,"given":"Chieh-Hsin","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan"},{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taipei, Taiwan"},{"name":"School of Medicine, Chang Gung University, Taoyuan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-230X","authenticated-orcid":false,"given":"Chih-Chiang","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei City Psychiatric Center, Taipei, Taiwan"},{"name":"Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2162-8174","authenticated-orcid":false,"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taipei, Taiwan"},{"name":"Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan"},{"name":"Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4713","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Holtzman DM, Morris JC, Goate AM<italic>. Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med 2011;3:77sr1<\/italic>.","DOI":"10.1126\/scitranslmed.3002369"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Levey A, Lah J, Goldstein F, Steenland K, Bliwise D<italic>. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer\u2019s disease. Clin Ther 2006;28:991-1001<\/italic>.","DOI":"10.1016\/j.clinthera.2006.07.006"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30272"},{"key":"ref4","unstructured":"Cardinali DP, Brusco LI, Liberczuk C, Furio AM<italic>. The use of melatonin in Alzheimer\u2019s disease. Neuro Endocrinol Lett 2002;23 Suppl 1:20-23<\/italic>."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01191.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1385\/endo:27:2:119"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(99)02102-2"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-06-02056.1998"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Villela D, Atherino VF, Lima Lde S, Moutinho AA, do Amaral FG, Peres R, <italic>et al<\/italic><italic>. Modulation of pineal melatonin synthesis by glutamate involves paracrine interactions between pinealocytes and astrocytes through NF-kB activation. Biomed Res Int 2013;2013:618432<\/italic>.","DOI":"10.1155\/2013\/618432"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-015-1677-z"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12114"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF<italic>. Early neuropathological Alzheimer\u2019s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J Pineal Res 2003;35:125-130<\/italic>.","DOI":"10.1034\/j.1600-079X.2003.00065.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Srinivasan V, Pandi-Perumal SR, Cardinali DP, Poeggeler B, Hardeland R<italic>. Melatonin in Alzheimer\u2019s disease and other neurodegenerative disorders. Behav Brain Funct 2006;2:15<\/italic>.","DOI":"10.1186\/1744-9081-2-15"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF<italic>. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer\u2019s disease, and apolipoprotein E-epsilon4\/4 genotype. J Clin Endocrinol Metab 1999;84:323-327<\/italic>.","DOI":"10.1210\/jcem.84.1.5394"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00086-8"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Cardinali DP, Furio AM, Brusco LI<italic>. Clinical aspects of melatonin intervention in Alzheimer\u2019s disease progression. Curr Neuro-pharmacol 2010;8:218-227<\/italic>.","DOI":"10.2174\/157015910792246209"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Cardinali DP, Furio AM, Brusco LI<italic>. The use of chronobiotics in the resynchronization of the sleep\/wake cycle. Therapeutical application in the early phases of Alzheimer\u2019s disease. Recent Pat Endocr Metab Immune Drug Discov 2011;5:80-90<\/italic>.","DOI":"10.2174\/187221411799015354"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009178.pub3"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.1.E11"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181aa52d3"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM<italic>. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer\u2019s disease. Neurology 1984;34:939-944<\/italic>.","DOI":"10.1212\/WNL.34.7.939"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.43.11.2412-a"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR<italic>. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198<\/italic>.","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Crum RM, Anthony JC, Bassett SS, Folstein MF<italic>. Population- based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391<\/italic>.","DOI":"10.1001\/jama.269.18.2386"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb01992.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2007.693"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb05004.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.6.566"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079x.1986.tb00760.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(93)90025-g"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Srinivasan V, Kaur C, Pandi-Perumal S, Brown GM, Cardinali DP<italic>. Melatonin and its agonist ramelteon in Alzheimer\u2019s disease: possible therapeutic value. Int J Alzheimers Dis 2010;2011:741974<\/italic>.","DOI":"10.4061\/2011\/741974"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wu YH, Swaab DF<italic>. The human pineal gland and melatonin in aging and Alzheimer\u2019s disease. J Pineal Res 2005;38:145-152<\/italic>.","DOI":"10.1111\/j.1600-079X.2004.00196.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.08.020"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079x.1996.tb00287.x"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000109141"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2016.05.005"},{"key":"ref37","unstructured":"Terzieva DD, Mateva ND, Vladimirova-Kitova LG<italic>. Melatonin reference limits at 3:00 AM and 8:00 AM in healthy adults. Clin Lab 2009;55:359-361<\/italic>."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2009.00736.x"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1873"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05347blu"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2006.42.4.970842"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2010.00778.x"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C, <italic>et al<\/italic><italic>. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer\u2019s disease. J Pineal Res 2004;37:129-136<\/italic>.","DOI":"10.1111\/j.1600-079X.2004.00144.x"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0014"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.04.055"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12360"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/s1570-0232(02)00168-x"},{"key":"ref48","unstructured":"Olakowska E, Marcol W, Kotulska K, Lewin-Kowalik J<italic>. The role of melatonin in the neurodegenerative diseases. Bratisl Lek Listy 2005;106:171-174<\/italic>."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033887"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1352.008"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2614-x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0315-x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Wu YH, Swaab DF<italic>. The human pineal gland and melatonin in aging and Alzheimer\u2019s disease. J Pineal Res 2005;38:145-152<\/italic>.","DOI":"10.1111\/j.1600-079X.2004.00196.x"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.08.010"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-01-14.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-01-14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T05:37:49Z","timestamp":1723009069000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2,28]]}},"alternative-id":["10.9758\/cpn.2021.19.1.135"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2021.19.1.135","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"value":"1738-1088","type":"print"},{"value":"2093-4327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.135","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.135","name":"the_journal","label":"Clinical Psychopharmacology and Neuroscience","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2020-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2021 The","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"name":"license","label":"License","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}